FDA calls for more broadly applicable drug development tools

被引：0

|

作者：

不详

机构：

来源：

NATURE REVIEWS DRUG DISCOVERY | 2010年 / 9卷 / 12期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

收藏

页码：907 / 907

页数：1

相关论文

共 50 条

[21] FDA advisers warn of more deaths if drug is relaunched
Moynihan, R
BRITISH MEDICAL JOURNAL, 2002, 325 (7364): : 561 - 561
[22] The FDA and IBS Drug Development Reply
Talley, Nicholas J.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (12): : 3106 - 3106
[23] FDA AD Drug Development Guidance
不详
JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (04) : 16N - 16N
[24] FDA Seeks More Timely Drug Information Electronically
Wechsler, Jill
BIOPHARM INTERNATIONAL, 2010, 23 (03) : 18 - 19
[25] FDA may give more details on drug sales
Cima, Greg
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2017, 251 (08): : 872 - 872
[26] FDA may allow more conditional drug approvals
不详
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2014, 245 (09): : 992 - 992
[27] FDA needs more sophisticated approach to drug safety
Christie, B
BRITISH MEDICAL JOURNAL, 2005, 330 (7501): : 1166 - 1166
[28] FDA pursues new policy on dietary supplements amid calls for more information, regulation
Wechsler, J
FORMULARY, 1999, 34 (11) : 972 - 973
[29] Harnessing pre-existing viral immunity for development of a broadly applicable tumor immunotherapy
Cuburu, Nicolas
Bialkowski, Lukas
Pontejo, Sergio M.
Bell, Alexander
Kim, Rina
Thompson, Cynthia D.
Lowy, Douglas R.
Schiller, John T.
CANCER RESEARCH, 2020, 80 (16)
[30] Cardboard, sticks not tools for drug making, FDA tells company
Reactions Weekly, 2013, 1446 (1) : 4 - 4

← 1 2 3 4 5 →